MICHELLE WHIPPLE: Open Payments
NPI 1992080691 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 20 payments from 3 companies in 2025. Trend: 2023 $264 · 2024 $388 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 15 | $220 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $82 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
Products named: LYBALVI, ARISTADA, CAPLYTA, COBENFY.
Industry payments across CA — which companies pay providers there.
